Lack of the effect of topical vitamin K on bruising after mechanical injury R.K Kovács, MD, L Bodai, A Dobozy, MD, PhD, DSC, L Kemény, MD, PhD, DSC Journal.

Slides:

Advertisements

Similar presentations

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted.

Advertisements

Jeff Donovan, MD, PhD, FRCPC JAAD Case Reports

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Facial adenocarcinoma treated with intra-arterial chemotherapy

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients Lucy Y. Liu, BA, Brittany.

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Baldness reversed by chemotherapy

Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment Tetsuya Honda, MD, PhD, Satoshi Koreeda, MD, PhD, Yoshiki Miyachi, MD,

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Sarah Sung, MD, Alexa B. Kimball, MD, MPH

Efficacy of topical application of eosin for ulcerated hemangiomas

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial Catherine Maari, MD, FRCPC, Philippe Marchessault,

Brad A. Yentzer, MD, Ali Alikhan, BS, Hoa Teuschler, MS, Lisa L

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Applying for dermatology residency is difficult and expensive

Kishore L. Jayakumar, BS, Sara S. Samimi, MD

Treatment of toxic epidermal necrolysis in North America

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Ampicillin-induced cutaneous eruption associated with Epstein-Barr virus reactivation Mamiko Saito-Katsuragi, MD, Hideo Asada, MD, PhD, Shoko Yokoi, MD,

Reply to: “Comment on ‘Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary.

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Reply to: “A note on normality”

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Fever, eosinophilia, and a rash

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades.

Infectious rash after riding elephants

Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream* Alexander Kreuter, MD, Bettina Hochdorfer, MD, Markus.

Lip edema Journal of the American Academy of Dermatology

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Leflunomide as adjuvant treatment of dermatomyositis

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Hugh Gloster, MD, Chesahna Kindred, MBA

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

A new oral anticoagulant in the setting of dermatologic surgery

Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation Suelen Montagner, MD, Francisco Aparecido.

Treatment of Hailey-Hailey disease with topical calcitriol

Donato Calisto, MD, Fabio Arcangeli, MD

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Pigmented purpuric dermatosis (capillaritis) induced by bezafibrate

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Photosensitive lichenoid drug eruption to capecitabine

Anastasia O. Kurta, DO, Daisy Dai, PhD, Eric S

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Lack of the effect of topical vitamin K on bruising after mechanical injury R.K Kovács, MD, L Bodai, A Dobozy, MD, PhD, DSC, L Kemény, MD, PhD, DSC Journal of the American Academy of Dermatology Volume 50, Issue 6, Pages 982-983 (June 2004) DOI: 10.1016/j.jaad.2004.01.057

Fig 1 The effect of 1-week treatment with vitamin K cream or placebo on capillary resistance (CR). A, Before treatment (vitamin K). B, Before treatment (placebo). C, After treatment (vitamin K). D, After treatment (placebo). There is a nonsignificant difference in the values of CR on both forearms (CRbefore: 27 kPa, CRafter: 28 kPa, n = 10, pvitaminK = .087, pplacebo = .104). Journal of the American Academy of Dermatology 2004 50, 982-983DOI: (10.1016/j.jaad.2004.01.057)

Fig 2 The number of induced petechiae after application of 40 kPa vacuum on the forearms of the patients. There was a slight but not significant difference in the number of petechiae between the vitamin K and placebo-treated sites on days 1, 2, and 3 (n = 10, p1 = .116; p2 = .072; p3 = .213). Journal of the American Academy of Dermatology 2004 50, 982-983DOI: (10.1016/j.jaad.2004.01.057)